Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea in Sickle Cell Anemia (MSH)
NCT00000586Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jan 1992
- Primary completion
- Jun 1994
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by National Heart, Lung, and Blood Institute. Started Jan 1992; status: completed.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT00000586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000586.